I anticipate that the new provision will initially be utilised by the director-general to enable fourth doses of the Pfizer COVID-19 vaccine to be rapidly rolled out to recommended at-risk groups without the need for a prescription in time for winter. This will, of course, be a decision for the director-general once the amendment comes into force.